As the first quarter of 2022 came to a close we continue to discover more about psychedelics and their apparent therapeutic potential. March was another busy month for psychedelic research with notable publications including a direct comparison of the effects elicited by psilocybin and LSD, escalating doses of LSD were safely administered in a novel intervention paradigm, while MDMA was shown to…


Previous articlePT312 – Deborah Snyder – Ecology, Synergy, and the Biosphere
Next articlePsychedelic Bulletin: Psychedelics X Big Pharma; $23m Round for At-Home Ketamine Therapy; Psychedelics Research Review